# Therapeutic Applications

**Doc-Type:** Discovery Module | Version 1.0 | Updated 2025-12-24

---

## Overview

The p-adic geometric framework enables multiple therapeutic applications for HIV - from vaccine design to personalized treatment optimization to novel glycan editing approaches.

---

## Application Roadmap

```mermaid
timeline
    title HIV P-Adic Applications Timeline
    section Immediate
        Drug Combo Optimization : Ready now
        Epitope Screening : Ready now
    section 6-12 Months
        Resistance Prediction Tool : Development
        Cross-clade Analysis : Validation
    section 1-2 Years
        Vaccine Immunogens : Wet lab testing
        Clinical Correlation : Data access
    section 3-5 Years
        Glycan Editing Therapy : Novel approach
        Functional Cure : Long-term goal
```

---

## Application 1: Vaccine Immunogen Design

### Concept

```mermaid
flowchart LR
    subgraph DESIGN["Immunogen Design Pipeline"]
        BG505["BG505 SOSIP.664"]
        MUT["Introduce N→Q<br/>at sentinel sites"]
        EXPRESS["Express & Purify"]
        TEST["Test bnAb Binding"]
        IMMUNIZE["Animal Immunization"]
    end

    BG505 --> MUT --> EXPRESS --> TEST --> IMMUNIZE

    PADIC["P-Adic Analysis"] -->|"Identifies<br/>sentinel sites"| MUT

    style PADIC fill:#74c0fc,stroke:#1864ab,stroke-width:2px
```

### Recommended Constructs

```mermaid
flowchart TB
    subgraph CONSTRUCTS["Vaccine Immunogen Designs"]
        C1["<b>DESIGN 1: Triple Sentinel</b><br/>N58Q + N103Q + N204Q<br/><br/>Targets: V1/V2 apex + V3 supersite<br/>bnAbs: PG9, PG16, PGT121, PGT128"]

        C2["<b>DESIGN 2: V1/V2 Focused</b><br/>N103Q + N107Q<br/><br/>Targets: V1/V2 apex only<br/>bnAbs: PG9, PG16, PGT145"]

        C3["<b>DESIGN 3: Sequential</b><br/>Prime: Deglycosylated (3-site)<br/>Boost: Native Env<br/><br/>Strategy: Broad prime + affinity maturation"]
    end

    style C1 fill:#69db7c,stroke:#2f9e44,stroke-width:2px
    style C2 fill:#b2f2bb,stroke:#2f9e44
    style C3 fill:#d3f9d8,stroke:#2f9e44
```

---

## Application 2: Drug Resistance Prediction

### Pipeline

```mermaid
flowchart LR
    subgraph PREDICT["Resistance Prediction Pipeline"]
        SEQ["Patient<br/>Sequence"] --> ENCODE["3-Adic<br/>Encoding"]
        ENCODE --> CALC["Calculate<br/>Escape d"]
        CALC --> RANK["Rank<br/>Mutations"]
        RANK --> GUIDE["Treatment<br/>Guidance"]
    end

    DB["Stanford HIVDB"] --> |"Known mutations"| ENCODE

    style GUIDE fill:#69db7c,stroke:#2f9e44,stroke-width:2px
```

### Clinical Decision Support

```mermaid
flowchart TB
    subgraph DECISION["Treatment Selection"]
        Q1{"Patient<br/>HLA Type?"}
        Q2{"Current<br/>Regimen?"}
        Q3{"Resistance<br/>History?"}

        REC1["<b>HIGH BARRIER</b><br/>INSTI + NRTI<br/>d ≈ 11.2"]
        REC2["<b>MODERATE</b><br/>INSTI + NNRTI<br/>d ≈ 10.5"]
        REC3["<b>AVOID</b><br/>NNRTI + PI alone<br/>d ≈ 8.9"]
    end

    Q1 --> Q2 --> Q3
    Q3 -->|"No resistance"| REC1
    Q3 -->|"Some history"| REC2
    Q3 -->|"Complex"| REC3

    style REC1 fill:#69db7c,stroke:#2f9e44,stroke-width:2px
    style REC3 fill:#ff6b6b,stroke:#c92a2a,color:#fff
```

---

## Application 3: Combination Therapy Optimization

### Geometric Barrier Concept

```mermaid
flowchart TB
    subgraph BARRIER["Total Escape Barrier"]
        D1["Drug 1 Escape d"] --> TOTAL["TOTAL BARRIER<br/>= d₁ + d₂ + d₃"]
        D2["Drug 2 Escape d"] --> TOTAL
        D3["Drug 3 Escape d"] --> TOTAL

        TOTAL --> HIGH["HIGH = Durable<br/>d > 10"]
        TOTAL --> LOW["LOW = Risky<br/>d < 9"]
    end

    style HIGH fill:#69db7c,stroke:#2f9e44
    style LOW fill:#ff6b6b,stroke:#c92a2a,color:#fff
```

### Combination Rankings

| Combination | Components | Total Barrier | Recommendation |
|:------------|:-----------|:--------------|:---------------|
| **INSTI + NRTI + NRTI** | DTG + TAF + FTC | ~15.1 | OPTIMAL |
| **INSTI + NRTI** | DTG + TAF | ~11.2 | Excellent |
| **INSTI + NNRTI** | DTG + EFV | ~10.5 | Good |
| NNRTI + NRTI | EFV + TDF | ~9.5 | Moderate |
| NNRTI + PI | EFV + ATV | ~8.9 | Caution |

---

## Application 4: Elite Controller Research

### Geometric Trap Identification

```mermaid
flowchart TB
    subgraph TRAP["Identifying Geometric Traps"]
        SCREEN["Screen all<br/>HLA-epitope pairs"]
        ENCODE["Encode epitopes<br/>+ escape variants"]
        CALC["Calculate<br/>escape distances"]
        FILTER["Filter d > 6.0"]
        TARGET["Elite Controller<br/>Targets"]
    end

    SCREEN --> ENCODE --> CALC --> FILTER --> TARGET

    style TARGET fill:#69db7c,stroke:#2f9e44,stroke-width:2px
```

### Known High-Distance Epitopes

```mermaid
flowchart LR
    subgraph ELITE["Elite Controller Epitopes (d > 6.0)"]
        E1["KK10 / B27<br/>d = 7.38"]
        E2["FL8 / A24<br/>d = 7.37"]
        E3["TW10 / B57<br/>d = 6.34"]
    end

    VACCINE["CTL-Based<br/>Vaccine"] --> ELITE

    style E1 fill:#ff6b6b,stroke:#c92a2a,color:#fff
    style E2 fill:#ff6b6b,stroke:#c92a2a,color:#fff
    style E3 fill:#ff8787,stroke:#c92a2a,color:#fff
```

---

## Application 5: Glycan Editing Therapy (Novel)

### Concept

```mermaid
flowchart TB
    subgraph EDIT["Glycan Editing Therapy"]
        GAC["<b>Glycosidase-Antibody Conjugate</b>"]

        STEP1["1. Antibody targets<br/>HIV Env on infected cell"]
        STEP2["2. Glycosidase removes<br/>sentinel glycans"]
        STEP3["3. Epitopes exposed<br/>to bnAbs"]
        STEP4["4. bnAbs bind &<br/>clear infected cell"]
    end

    GAC --> STEP1 --> STEP2 --> STEP3 --> STEP4

    RESERVOIR["Latent<br/>Reservoir"] --> |"Targeted"| STEP1
    CURE["Functional<br/>Cure?"] --> STEP4

    style GAC fill:#b197fc,stroke:#7048e8,stroke-width:2px
    style CURE fill:#69db7c,stroke:#2f9e44,stroke-width:2px
```

### Development Pathway

```mermaid
gantt
    title Glycan Editing Development
    dateFormat YYYY-MM
    section In Vitro
        Glycosidase selection       :done, 2025-01, 3M
        Conjugation chemistry       :active, 2025-04, 4M
        Cell-based assays           :2025-08, 4M
    section In Vivo
        Animal model design         :2026-01, 3M
        Efficacy testing            :2026-04, 6M
        Toxicology                  :2026-10, 6M
    section Clinical
        IND preparation             :2027-04, 6M
        Phase I trial               :2027-10, 12M
```

---

## Application 6: Universal Vaccine Targets

### Cross-Clade Sentinel Analysis

```mermaid
flowchart TB
    subgraph UNIVERSAL["Universal Vaccine Target Discovery"]
        CLADES["Analyze all<br/>HIV-1 Clades"]
        SENTINEL["Run sentinel<br/>analysis per clade"]
        INTERSECT["Find intersection:<br/>Conserved sentinels"]
        DESIGN["Design universal<br/>immunogen"]
    end

    CLADES --> SENTINEL --> INTERSECT --> DESIGN

    CLADE_A["Clade A"] --> CLADES
    CLADE_B["Clade B"] --> CLADES
    CLADE_C["Clade C"] --> CLADES
    CLADE_D["Clade D"] --> CLADES
    CRF["CRFs"] --> CLADES

    style DESIGN fill:#69db7c,stroke:#2f9e44,stroke-width:2px
```

---

## Application 7: Computational Platform

### API Concept

```mermaid
flowchart LR
    subgraph API["HIV P-Adic API"]
        ANALYZE["analyze_mutation()"]
        RANK["rank_epitopes()"]
        OPTIMIZE["optimize_immunogen()"]
        PREDICT["predict_resistance()"]
    end

    USER["Researcher"] --> API
    API --> RESULTS["Results:<br/>Distances, Rankings,<br/>Designs"]

    style API fill:#74c0fc,stroke:#1864ab,stroke-width:2px
```

### Example Usage

```python
from hiv_padic import HIVAnalyzer

# Initialize with encoder
analyzer = HIVAnalyzer(encoder="3adic_v5.11.3")

# Analyze a mutation
result = analyzer.analyze_mutation("RT", "M184V")
print(f"Escape distance: {result.distance}")  # 4.00

# Rank epitopes for a patient
epitopes = analyzer.rank_epitopes(
    patient_hla=["B*27:05", "A*02:01"]
)
# Returns sorted by escape barrier

# Optimize immunogen design
design = analyzer.optimize_immunogen(
    target_bnabs=["VRC01", "PGT121"],
    max_sites=3
)
# Returns: ["N58Q", "N103Q", "N204Q"]

# Predict resistance risk
risk = analyzer.predict_resistance(
    patient_sequence="...",
    regimen=["DTG", "TAF", "FTC"]
)
# Returns per-mutation probability
```

---

## Impact Summary

```mermaid
quadrantChart
    title Application Impact vs Timeline
    x-axis Near-Term --> Long-Term
    y-axis Low Impact --> High Impact
    quadrant-1 "High-Impact Long-Term"
    quadrant-2 "High-Impact Near-Term"
    quadrant-3 "Lower Priority"
    quadrant-4 "Moderate Priority"

    "Combo Optimization": [0.15, 0.55]
    "Resistance Prediction": [0.25, 0.60]
    "Vaccine Design": [0.55, 0.80]
    "Elite Research": [0.60, 0.70]
    "Glycan Editing": [0.80, 0.90]
    "Functional Cure": [0.95, 0.95]
```

---

## Priority Matrix

| Application | Timeline | Impact | Resources | Priority |
|:------------|:---------|:-------|:----------|:---------|
| Combo Optimization | Immediate | Medium | Low | **1** |
| Resistance Prediction | 6-12 mo | Medium | Medium | **2** |
| Vaccine Immunogens | 1-2 yr | High | High | **3** |
| Elite Controller Research | 2-3 yr | High | Medium | **4** |
| Glycan Editing | 3-5 yr | Very High | Very High | **5** |
| Functional Cure | 5+ yr | Transformative | Very High | **6** |

---

## Related Documents

- [Drug Resistance Profiles](./01_DRUG_RESISTANCE_PROFILES.md)
- [Elite Controllers](./02_ELITE_CONTROLLERS.md)
- [Sentinel Glycans](./03_SENTINEL_GLYCANS.md)
- [Validation Results](./05_VALIDATION_RESULTS.md)

---

**Navigation:** [← Sentinel Glycans](./03_SENTINEL_GLYCANS.md) | [Index](./README.md) | [Validation →](./05_VALIDATION_RESULTS.md)
